Recruiting

LIVInG With chrONic Cancer TrEatments (LONGEVITI) Study

People with advanced chronic cancers are now living for many years as a result of new targeted anti-cancer treatments. Many of these treatments are quite new and people may take them for months, even years, as long as the treatments are helping. The purpose of this study is to help understand how to best support people receiving these treatments.

ClinicalTrials.gov IDNCT05645510
PhaseNot Applicable
Enrollment75
SponsorUniversity of Alberta
Age18 Years
SexALL
I'm interested View official listing

Conditions studied

Cancer, Tyrosine Kinase Mutation, Breast Cancer, Melanoma, Multiple Myeloma, Chronic Leukemia, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Lung Cancer

About this study

People with advanced chronic cancers are now living for many years as a result of new targeted anti-cancer treatments. Many of these treatments are quite new and people may take them for months, even years, as long as the treatments are helping. The purpose of this study is to help understand how to best support people receiving these treatments.

Primary outcomes

Eligibility information

Inclusion Criteria: taking chronic targeted anti-cancer agents - Exclusion Criteria: \-

Study locations

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.